Why Health Care Was Unprepared for the 2022 RSV Surge
A pediatric emergency medicine physician discusses the epidemic factors that still perturb experts, and the status of vaccination and treatment strategies.
New Technologies, Type 2 Diabetes, and Cardiovascular Prevention
Limitations managing type 2 diabetes with new technologies used as monitoring tools that need to be addressed moving forward.
Hybrid Artificial Insulin Pump Systems for T2DM
A description of hybrid artificial insulin pump systems for type 2 diabetes and a discussion highlighting potential integration with continuous glucose monitoring systems.
Integrating Continuous Glucose Monitoring Systems into Clinical Practice
Recommendations to address accessibility and coverage issues that affect the use of continuous glucose monitoring into widespread clinical practice.
Continuous Glucose Monitoring Systems for T2DM
A discussion on using continuous glucose monitoring systems to improve the management of type 2 diabetes.
Benefits of New Therapies Used to Treat T2DM
The benefits of using new therapies, such as SGLT2 inhibitors and GLP-1 receptor agonists, to treat type 2 diabetes.
Revised ADA Guideline Recommendations for the Treatment of T2DM
Takeaways of the most recent ADA guidelines in terms of treating patients with diabetes with metformin, SGLT2 inhibitors, and GLP-1 receptor agonists.
Updated Guidance Regarding Aspirin Use and CVD Prevention
Guidance on the use of aspirin therapy in patients at risk of cardiovascular events, based on recently updated guideline recommendations.
Statin Therapies and Treatment-Related Myalgias
How to best prevent and manage statin-associated myalgias when managing cholesterol levels in patients with type 2 diabetes at risk for cardiovascular events.
Cholesterol-Lowering Therapies for CVD Prevention in T2DM
Considerations that factor into decisions for reducing LDL levels in patients with diabetes with statin therapy or options, such as PCSK9 inhibitors and ezetimibe.
Blood Pressure Management and CVD Prevention in T2DM
Updated guideline recommendations regarding the monitoring and management of patients’ blood pressure levels to reduce the risk of cardiovascular events.
Geographic Disparities in T2DM and CVD Prevention
A call to action for more focus on the management of the type 2 diabetes epidemic around the globe.
Approaching Treatment for Patients With Psoriatic Arthritis
Optimizing Care With a Multidisciplinary Approach
Looking Toward the Future in Plaque Psoriasis
IL-17, IL-23 Blockers for Treatment of Plaque Psoriasis
TNF Blockers as First-Line Therapy for Psoriatic Disease
Treatment of Psoriatic Arthritis With Nonbiologic Agents
Using Oral Systemic Agents for Psoriatic Arthritis Treatment
Standard of Care: Psoriatic Arthritis and Plaque Psoriasis
Assessing Individual Patient Needs With Plaque Psoriasis
Challenges in the Management of Psoriatic Arthritis
Psoriatic Arthritis: Physical and Social Burdens
Triggers of Joint Disease
Clinical Manifestations of Psoriatic Diseases
Lobbying for Improved FCS Testing
FCS Treatment Advice for Clinicians and Caregivers
Unmet Needs in FCS Management
The Importance of Creating Awareness for FCS
The Impact of FCS on Quality of Life
2 Clarke Drive Cranbury, NJ 08512